Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,505 | 2,309 | 1,872 | 1,674 | 1,590 |
| Operating Income | -2,505 | -2,309 | -1,872 | -1,674 | -1,590 |
| Other Income | 113 | 143 | 103 | 48 | 66 |
| Pre-tax Income | -2,392 | -2,166 | -1,769 | -1,626 | -1,524 |
| Net Income Continuous | -2,392 | -2,166 | -1,769 | -1,626 | -1,524 |
| Net Income | $-2,392 | $-2,166 | $-1,769 | $-1,626 | $-1,524 |
| EPS Basic Total Ops | -0.44 | -0.45 | -0.41 | -3.45 | -1.54 |
| EPS Basic Continuous Ops | -0.44 | -0.45 | -0.41 | -3.46 | -1.54 |
| EPS Diluted Total Ops | -0.44 | -0.45 | -0.41 | -3.45 | -1.54 |
| EPS Diluted Continuous Ops | -0.44 | -0.45 | -0.41 | -3.46 | -1.54 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.45 | -0.41 | -0.85 | -1.54 |
| EBITDA(a) | $-2,505 | $-2,309 | $-1,872 | $-1,674 | $-1,590 |